Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multistage microrobots with pH-responsive release of platelet membrane-coated nanoparticles.

Science advances·2026
Same author

A Dural Extracellular Matrix Hydrogel with Neural Stem Cells Improves Recovery from Traumatic Brain Injury in Mice.

ACS biomaterials science & engineering·2026
Same author

BODIPY Photocage-Based Injectable Hydrogel for Light-Controlled Nanoparticle Release.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Bionano Interface Optimization for Rational Lateral Flow Assay Development.

ACS nano·2026
Same author

Image-guided optimization of regenerative graft attachment to the heart.

Biomaterials·2026
Same author

Towards intelligent and miniaturized drug delivery devices.

Nature·2026

Related Experiment Video

Updated: Mar 9, 2026

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.4K

Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

James P K Armstrong1, Margaret N Holme1, Molly M Stevens1

  • 1Department of Materials, Department of Bioengineering, and Institute for Biomedical Engineering, Imperial College London , London SW7 2AZ, United Kingdom.

ACS Nano
|January 10, 2017
PubMed
Summary

Extracellular vesicles (EVs) are promising cell-free therapeutics. This review details methods for chemically or biologically modifying EVs to enhance their therapeutic potential for various diseases.

Keywords:
cell-free therapydrug loadingexosomesextracellular vesiclesfunctionalizationgenetic manipulationmembrane modificationmicrovesicles

More Related Videos

Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

971
Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles
05:36

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

1.9K

Related Experiment Videos

Last Updated: Mar 9, 2026

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.4K
Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

971
Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles
05:36

Author Spotlight: Development of a Large-Scale, Reproducible Production Method for Exosome Mimetics Using Magnetic Nanoparticles

Published on: January 26, 2024

1.9K

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Nanotechnology

Background:

  • Extracellular vesicles (EVs) are emerging as key cell-free therapeutics for diseases like cancer and inflammatory conditions.
  • Their inherent stability, biocompatibility, and cell communication capabilities drive their therapeutic potential.
  • The field is advancing from in vitro studies to in vivo models and early clinical trials.

Purpose of the Study:

  • To review methods for chemically or biologically modifying extracellular vesicles (EVs).
  • To explore strategies for enhancing or altering the therapeutic capabilities of EVs.
  • To evaluate the complexities and opportunities of EV re-engineering.

Main Methods:

  • Modification of parent cells (genetic/metabolic engineering, exogenous material incorporation).
  • Direct functionalization of EVs (hydrophobic insertion, covalent chemistry, membrane permeabilization).
  • Introduction of nanoparticles, reporter systems, peptides, drugs, and RNA molecules into EVs.

Main Results:

  • Two broad strategies for EV modification are discussed: parent cell manipulation and direct EV functionalization.
  • Various therapeutic payloads can be incorporated into EVs using these methods.
  • The review provides historical context, examples, and evaluations of different re-engineering approaches.

Conclusions:

  • EV modification offers significant potential to broaden therapeutic applications.
  • Understanding the complexities and pitfalls of re-engineering is crucial for successful therapeutic development.
  • Further research into EV re-engineering strategies will accelerate their clinical translation.